PuraPharm Corporation Limited (01498.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.6x

Market Cap

HKD 125.35M

MomentumView details →

1D Return

+3.85%

YTD Return

−23.94%

RSI (14)

40.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.6x

Market Cap

HKD 125.35M

RSI (14)

40.6

MomentumView details →

1D Return

+3.85%

YTD Return

−23.94%

ProfitabilityView details →

Gross Margin

54.25%

Net Margin

−9.88%

EBITDA Margin

4.96%

ROE (TTM)

−52.99%

ROA (TTM)

−9.46%

Asset Turnover

0.96x

GrowthView details →

Revenue YoY

−19.42%

EPS YoY

+69.87%

FCF YoY

−26.44%

Revenue CAGR 3Y

−9.14%

EPS CAGR 3Y

+6.24%

EBITDA YoY

+143.82%

EarningsView details →

EPS (Actual)

−HKD 0.03

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

2.97x

Current Ratio

0.46x

Quick Ratio

0.23x

Div Yield

—

Div Rate

—

Div Growth 1Y

−77.28%

Financials snapshotView financials →

Revenue (TTM)

670.25M

Net Income (TTM)

−66.22M

Op. CF (TTM)

50.03M

Next earningsMar 31, 2027 →

Latest newsMore news →

No recent news for 01498.HK.

Similar companies

BGM Group Ltd.BGM Assertio Holdings, Inc.ASRT Procaps Group S.A.PROC Cumberland Pharmaceuticals Inc.CPIX Shenzhen Neptunus Interlong Bio-technique Company Limited08329.HK Organigram Global Inc.OGI Find similar companies →

Latest newsMore news →

No recent news for 01498.HK.